Why is Balaxi Pharma falling/rising?

As of 08-Oct, Balaxi Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 42.69, which reflects a decrease of Rs 0.92 or 2.11%. The stock is trading close to its 52-week low, just 1.22% away from Rs 42.17. It has underperformed its sector by 1.57% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -4.13%, and its year-to-date performance shows a significant decline of -40.96%. The rising investor participation, with a delivery volume increase of 33.06% against the 5-day average, indicates some interest, but overall, the stock's performance remains weak.
In the broader market context, the Sensex has shown a positive return of +0.84% over the past week, contrasting sharply with Balaxi Pharmaceuticals' negative performance. This divergence highlights the stock's struggles relative to the benchmark index. While the stock's liquidity appears sufficient for trading, the overall negative sentiment surrounding Balaxi Pharmaceuticals, reflected in its substantial declines over various timeframes, suggests that investors are cautious. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.